What is Cellevate?
Cellevate AB is a pioneering biotech firm at the forefront of developing next-generation cell culture products for upstream bioprocessing. Leveraging its proprietary Cellevat3d nanofiber technology, the company delivers innovative solutions designed to substantially increase yield and reduce production costs for viral vaccines and gene therapies. A key aspect of Cellevate's approach is its commitment to sustainability, utilizing biodegradable materials in its product development. The company actively engages in collaborations with global Contract Development and Manufacturing Organizations (CDMOs) and biopharmaceutical firms, aiming to accelerate advancements in bioproduction. Their product suite is engineered for scalability, catering to both research and large-scale commercial applications.
How much funding has Cellevate raised?
Cellevate has raised a total of $7.2M across 1 funding round:
Angel/Seed
$7.2M
Angel/Seed (2024): $7.2M with participation from The European Innovation Council and Industrifonden
Key Investors in Cellevate
The European Innovation Council
The European Innovation Council is an entity operating within the Colleges & Universities sector, focused on fostering innovation and technological advancement.
Industrifonden
Industrifonden is a Swedish venture capital fund dedicated to investing in unique, scalable innovations that aim to improve society through breakthrough technologies and science, with a focus on deep tech and life sciences.
What's next for Cellevate?
The recent major enterprise-level funding positions Cellevate AB for significant expansion and further technological development. This strategic investment is likely to fuel the scaling of its proprietary nanofiber technology, enabling broader adoption across the biopharmaceutical industry. Expect Cellevate to enhance its production capabilities and potentially forge new partnerships to solidify its market presence in the competitive cell culture and bioprocessing arena. The company's focus on yield enhancement and cost reduction, coupled with its sustainable material approach, aligns well with current industry trends and regulatory demands, suggesting a strong trajectory for future growth and innovation.
See full Cellevate company page
